Small cell lung cancer cell lines secrete predominantly ACTH precursor peptides not ACTH.
A panel of 18 well characterised human small cell lung cancer (SCLC) cell lines was assessed for the production of adrenocorticotrophin (ACTH) and its precursor peptides, pro-opiomelanocortin (POMC) and pro-ACTH. These precursor peptides were measured directly using a novel two-site immunoradiometric assay (IRMA) based on monoclonal antibodies, in conjunction with a similar IRMA for ACTH 1-39. Significant concentrations of ACTH precursors were secreted by 10 of the 18 cell lines (56%). The low levels of ACTH immunoreactivity detected in seven cell lines could be accounted for by the known cross-reactivity of precursors in the ACTH IRMA. This suggests there is little, if any, processing of ACTH precursors to ACTH. Cell pellet extracts contained undetectable or low levels of ACTH precursors and ACTH, indicating that these peptides are not stored intracellularly. During the growth of the SCLC cells in vitro ACTH precursors accumulated progressively in the culture medium. Thus the combination of a direct assay for the ACTH precursors and the panel of SCLC cell lines provides a valuable in vitro model for the expression of POMC in human tumours.
Stewart
M F
MF
University of Manchester, Department of Clinical Biochemistry, Hope Hospital, Salford, UK.
Crosby
S R
SR
Gibson
S
S
Twentyman
P R
PR
White
A
A
D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D018288:Carcinoma, Small Cell / Q000378:metabolism*; D002460:Cell Line; D006801:Humans; D008175:Lung Neoplasms / Q000378:metabolism*; D011333:Pro-Opiomelanocortin / Q000378:metabolism; D011498:Protein Precursors / Q000378:metabolism*; D014407:Tumor Cells, Cultured / Q000378:metabolism
D011498:Protein Precursors; D011333:Pro-Opiomelanocortin; D000324:Adrenocorticotropic Hormone